BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 29197605)

  • 1. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model.
    Freeman J; Chen A; Weinberg RJ; Okada T; Chen C; Lin PH
    Ann Vasc Surg; 2018 May; 49():295-303. PubMed ID: 29197605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
    Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
    J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass.
    Kaisar J; Chen A; Cheung M; Kfoury E; Bechara CF; Lin PH
    Vascular; 2018 Apr; 26(2):117-125. PubMed ID: 28835186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
    Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
    J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results.
    Bosiers M; Deloose K; Verbist J; Schroë H; Lauwers G; Lansink W; Peeters P
    J Vasc Surg; 2006 Feb; 43(2):313-8; discussion 318-9. PubMed ID: 16476607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
    Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
    J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of precuffed expanded polytetrafluorothylene and heparin-bonded polytetrafluorothylene graft in crural bypass.
    Bellosta R; Natalini G; Luzzani L; Carugati C; Sarcina A
    Ann Vasc Surg; 2013 Feb; 27(2):218-24. PubMed ID: 23092735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of femorocrural bypasses performed with modified heparin-bonded expanded polytetrafluorethylene grafts and those with great saphenous vein grafts to treat critical limb ischemia.
    Gessaroli M; Tarantini S; Leone M; Fabbri E; Panzini I
    Ann Vasc Surg; 2015 Aug; 29(6):1255-64. PubMed ID: 26025478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
    Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
    J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
    J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model.
    Pedersen G; Laxdal E; Ellensen V; Jonung T; Mattsson E
    J Cardiovasc Surg (Torino); 2010 Jun; 51(3):443-8. PubMed ID: 20523297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midterm Results of a Japanese Prospective Multicenter Registry of Heparin-Bonded Expanded Polytetrafluoroethylene Grafts for Above-the-Knee Femoropopliteal Bypass.
    Shibutani S; Obara H; Matsubara K; Toya N; Isogai N; Ogino H; Watada S; Asami A; Kudo T; Kanaoka Y; Fujimura N; Harada H; Uchiyama H; Sato Y; Ohki T;
    Circ J; 2020 Feb; 84(3):501-508. PubMed ID: 32062636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
    Gessaroli M; Bombardi C; Giunti M; Bacci ML
    J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics.
    Dorigo W; Pulli R; Castelli P; Dorrucci V; Ferilli F; De Blasis G; Monaca V; Vecchiati E; Pratesi C;
    J Vasc Surg; 2011 Nov; 54(5):1332-8. PubMed ID: 21840151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization.
    Begovac PC; Thomson RC; Fisher JL; Hughson A; Gällhagen A
    Eur J Vasc Endovasc Surg; 2003 May; 25(5):432-7. PubMed ID: 12713782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic Heparan Sulfate-Like Coated ePTFE Grafts Reduce In-graft Neointimal Hyperplasia in Ovine Carotids.
    Wulff B; Stahlhoff S; Vonthein R; Schmidt A; Sigler M; Torsello GB; Herten M
    Ann Vasc Surg; 2017 Apr; 40():274-284. PubMed ID: 28163179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact analysis of heparin-bonded polytetrafluoroethylene grafts (Propaten) against standard polytetrafluoroethylene grafts for below-the-knee bypass in patients with critical limb ischaemia in France.
    Vergnaud S; Riche VP; Tessier P; Mauduit N; Kaladji A; Gouëffic Y
    BMJ Open; 2018 Feb; 8(2):e017320. PubMed ID: 29490953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Greisler HP
    Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.